Smoothened antagonists: a promising new class of antitumor agents

Author： Gallinari Paola Filocamo Gessica Jones Philip Pazzaglia Simonetta Steinkühler Christian

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.4, Iss.5, 2009-05, pp. : 525-544

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

SCAP ligands: promising new class of lipid-lowering agents

Inpharma, Vol. 1, Iss. 1323, 2002-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Vasopressin-Receptor Antagonists: A New Class of Agents for the Treatment of Hyponatremia

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 6, Iss. 3, 2006-09 ,pp. : 249-258

Bentham Science Publishers

Access to resources Recommend Favorite

Antagonists of IAP Proteins: Novel Anti-Tumor Agents

Current Medicinal Chemistry, Vol. 21, Iss. 34, 2014-01 ,pp. : 3877-3892

Bentham Science Publishers

Access to resources Recommend Favorite

Small-Molecule Antagonists of CCR5 and CXCR4: A Promising New Class of Anti-HIV-1 Drugs

Current Pharmaceutical Design, Vol. 10, Iss. 17, 2004-07 ,pp. : 2041-2062

Bentham Science Publishers

Access to resources Recommend Favorite

Arylsulphones: A Promising Class of Non-Nucleoside Antiviral Agents

Current Medicinal Chemistry - Anti-Infective Agents, Vol. 4, Iss. 2, 2005-04 ,pp. : 167-183

Bentham Science Publishers

Access to resources Recommend Favorite